Jae-Won Soh

Title: Jae-Won Soh: Innovator in Neoplasia Treatment

Jae-Won Soh is a notable inventor based in Cliffside Park, NJ (US). He has made significant contributions to the field of medical research, particularly in the treatment of neoplasia. His innovative approach has the potential to impact the lives of many individuals affected by this condition.

Latest Patents

Jae-Won Soh holds a patent for a method titled "Method for screening compounds for the treatment of neoplasia." This invention provides a method to identify compounds that may be useful for the treatment and prevention of neoplasia in mammals. The process involves determining the phosphodiesterase inhibitory activity of a compound, as well as its ability to elevate JNK kinase activity. Additionally, the growth inhibitory and apoptosis-inducing effects on cultured tumor cells are assessed. Compounds that demonstrate phosphodiesterase inhibition, an ability to elevate JNK kinase activity, and induce growth inhibition and apoptosis are considered desirable for the treatment of neoplasia.

Career Highlights

Jae-Won Soh is associated with Cell Pathways, a company dedicated to advancing medical research and treatment options. His work at Cell Pathways has allowed him to focus on innovative solutions for complex medical challenges. With a patent portfolio that includes one significant patent, he has established himself as a key figure in the field of neoplasia research.

Collaborations

Jae-Won Soh has collaborated with esteemed colleagues, including I Bernard Weinstein and W Joseph Thompson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Jae-Won Soh's contributions to the field of neoplasia treatment through his innovative patent demonstrate his commitment to improving medical outcomes. His work at Cell Pathways and collaborations with other professionals highlight the importance of teamwork in advancing scientific research.